Sabby Management’s VolitionRx Ltd VNRX Stock Holding History

Sabby Management’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-658	Closed	-$32K	–	183
2018 Q1	$32K	Buy	+658	New	+$38.5K	﹤0.01%	144

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

Sabby Management's VNRX Position: Q2 2018 in Review

Sabby Management sold out of VolitionRx Ltd (VNRX) in Q2 2018, closing a stake of 658 shares — an estimated $32K sold.

Sabby Management first reported a position in VNRX in Q1 2018 and held it in 1 quarter. The position peaked at $32K in Q1 2018. 24 funds tracked by Wall St. Rank hold VNRX as of Q2 2018.

Sabby Management reported no remaining VolitionRx Ltd position as of Q2 2018 after selling out during the quarter.
Sabby Management sold 658 VolitionRx Ltd shares in Q2 2018, an estimated $32K.
Sabby Management first reported a position in VolitionRx Ltd in Q1 2018 and held it in 1 quarter.
Sabby Management's VolitionRx Ltd position peaked at $32K in Q1 2018.
24 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2018.

Based on Sabby Management's 13F filing for Q2 2018, filed 14 Aug 2018.